Combitaz Injection

Combitaz Injection is a prescription medicine that blends two active agents, ceftazidime and tazobactam. This combination is given to manage a wide range of bacterial infections, including those affecting the lungs, urinary system, skin, abdomen, and blood. By working together, these two medicines stop the growth of harmful bacteria and prevent them from developing resistance, making treatment more effective.

This injection is always administered by a healthcare professional under medical supervision. The amount and duration depend on the severity of the infection, age, and overall health of the patient. Even if improvement is seen quickly, it is important to complete the full course as advised by the doctor to avoid the infection from returning or becoming harder to treat.

During treatment, some individuals may notice mild effects such as nausea, loose motions, stomach discomfort, vomiting, headache, or temporary changes in liver function tests. Sometimes, irritation at the injection site or allergic reactions may also occur. Most of these are short-lasting, but it is advisable to seek medical help if they persist or seem troubling.

Patients with a history of liver or kidney problems, pregnant or breastfeeding women, or those taking other medicines should share this information with their doctor before starting the injection. It is also recommended to avoid activities that require alertness, such as driving, if dizziness or drowsiness occurs after the dose.

The medicine works by breaking down the bacterial cell wall (through ceftazidime) and blocking enzymes that cause resistance (with the help of tazobactam). This dual action makes it more reliable against tough or resistant infections.